Predictive value of 3′-deoxy-3′-18F-fluorothymidine PET in the early response to anti-programmed death-1 therapy in patients with advanced non-small cell lung cancer
Background Anti-programmed death-1 (anti-PD-1) therapy has shown clinical success in patients with advanced non-small cell lung cancer (NSCLC). However, it is difficult to evaluate the early response to anti-PD-1 therapy. We determined whether changes in 3′-deoxy-3′-[18F]-fluorothymidine (18F-FLT) P...
Saved in:
| Main Authors: | Yukihiro Umeda, Miwa Morikawa, Masaki Anzai, Maiko Kadowaki, Yuko Waseda, Tetsuya Tsujikawa, Yasushi Kiyono, Hidehiko Okazawa, Tamotsu Ishizuka, Masayuki Sato, Tetsuya Mori |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-07-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/9/7/e003079.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
3′-deoxy-3′-18F-fluorothymidine PET imaging of lymphoid tissues in patients with advanced non-small cell lung cancer undergoing anti-programmed cell death-1 therapy
by: Masayuki Sato, et al.
Published: (2025-04-01) -
Predictive value of integrated 18F-FDG PET/MRI in the early response to nivolumab in patients with previously treated non-small cell lung cancer
by: Yukihiro Umeda, et al.
Published: (2020-05-01) -
Phosphorylation status of thymidine kinase 1 following antiproliferative drug treatment mediates 3'-deoxy-3'-[18F]-fluorothymidine cellular retention.
by: Roberta Sala, et al.
Published: (2014-01-01) -
Relationship between renal oxidative stress levels and disease severity in patients with chronic kidney disease assessed by [Cu-64]ATSM PET/MRI
by: Ya’nan Huang, et al.
Published: (2025-02-01) -
Antiangiogenic activity of 2-deoxy-D-glucose.
by: Jaime R Merchan, et al.
Published: (2010-10-01)